Trial: 201812035

RNA Disruption Assay (RDA) – Breast cancer Response EValuation for Individualized TherapY (BREVITY)

Phase

N/A

Principal Investigator

Ademuyiwa, Foluso

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov